EP1268510A4 - METHOD AND MATERIALS RELATING TO POLYPEPTIDES AND POLYNUCLEOTIDES LIKE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN - Google Patents
METHOD AND MATERIALS RELATING TO POLYPEPTIDES AND POLYNUCLEOTIDES LIKE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINInfo
- Publication number
- EP1268510A4 EP1268510A4 EP01928344A EP01928344A EP1268510A4 EP 1268510 A4 EP1268510 A4 EP 1268510A4 EP 01928344 A EP01928344 A EP 01928344A EP 01928344 A EP01928344 A EP 01928344A EP 1268510 A4 EP1268510 A4 EP 1268510A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- polynucleotides
- insulin
- polypeptides
- growth factor
- binding protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4743—Insulin-like growth factor binding protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54021700A | 2000-03-31 | 2000-03-31 | |
| US540217 | 2000-03-31 | ||
| US64916700A | 2000-08-23 | 2000-08-23 | |
| US649167 | 2000-08-23 | ||
| US78474801A | 2001-02-14 | 2001-02-14 | |
| US784748 | 2001-02-14 | ||
| PCT/US2001/010462 WO2001075064A2 (en) | 2000-03-31 | 2001-03-30 | Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1268510A2 EP1268510A2 (en) | 2003-01-02 |
| EP1268510A4 true EP1268510A4 (en) | 2003-05-28 |
Family
ID=27415319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP01928344A Withdrawn EP1268510A4 (en) | 2000-03-31 | 2001-03-30 | METHOD AND MATERIALS RELATING TO POLYPEPTIDES AND POLYNUCLEOTIDES LIKE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1268510A4 (en) |
| JP (1) | JP2004500120A (en) |
| AU (2) | AU5521401A (en) |
| CA (1) | CA2404501A1 (en) |
| WO (1) | WO2001075064A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002081515A1 (en) * | 2001-04-03 | 2002-10-17 | Kyowa Hakko Kogyo Co., Ltd. | Insulin-like growth factor-binding protein |
| CA2484000A1 (en) | 2002-05-24 | 2003-12-04 | Schering Corporation | Neutralizing human anti-igfr antibody |
| CA2541015A1 (en) | 2003-10-03 | 2005-04-14 | Genentech, Inc. | Igf binding proteins |
| JP2007510434A (en) | 2003-11-12 | 2007-04-26 | シェーリング コーポレイション | A plasmid system for multigene expression. |
| PE20050928A1 (en) | 2003-11-21 | 2005-11-08 | Schering Corp | THERAPEUTIC COMBINATIONS OF ANTI-IGFR1 ANTIBODY |
| ES2356830T3 (en) | 2004-12-03 | 2011-04-13 | Schering Corporation | BIOMARCATORS FOR PRESELECTION OF PATIENTS FOR ANTI-IGF-1R THERAPY. |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001075067A2 (en) * | 2000-03-31 | 2001-10-11 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| WO2001094416A2 (en) * | 2000-06-07 | 2001-12-13 | Curagen Corporation | Human proteins and nucleic acids encoding same |
-
2001
- 2001-03-30 EP EP01928344A patent/EP1268510A4/en not_active Withdrawn
- 2001-03-30 WO PCT/US2001/010462 patent/WO2001075064A2/en not_active Ceased
- 2001-03-30 AU AU5521401A patent/AU5521401A/en active Pending
- 2001-03-30 CA CA002404501A patent/CA2404501A1/en not_active Abandoned
- 2001-03-30 AU AU2001255214A patent/AU2001255214B2/en not_active Ceased
- 2001-03-30 JP JP2001572939A patent/JP2004500120A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001075067A2 (en) * | 2000-03-31 | 2001-10-11 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| WO2001094416A2 (en) * | 2000-06-07 | 2001-12-13 | Curagen Corporation | Human proteins and nucleic acids encoding same |
Non-Patent Citations (4)
| Title |
|---|
| DATABASE EMBL [online] 19 December 1999 (1999-12-19), XP002236615, retrieved from EBI Database accession no. AL135785 * |
| DATABASE GENESEQ NCBI; * |
| DEDERA DA, Director of Disease Biology, Functional Genomics Department, Hyseq Inc.: Declaration of 2002-10-18 on experiments supervised. * |
| HWA VIVIAN ET AL: "The insulin-like growth factor-binding protein (IGFBP) superfamily", ENDOCRINE REVIEWS, BALTIMORE, MD, US, vol. 20, no. 6, December 1999 (1999-12-01), pages 761 - 787, XP002211304 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2404501A1 (en) | 2001-10-11 |
| JP2004500120A (en) | 2004-01-08 |
| AU2001255214B2 (en) | 2006-06-08 |
| WO2001075064A3 (en) | 2002-02-28 |
| EP1268510A2 (en) | 2003-01-02 |
| WO2001075064A2 (en) | 2001-10-11 |
| AU5521401A (en) | 2001-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1121440E (en) | Improved expression of cry3b insecticidal protein in plants | |
| EE05538B1 (en) | Interleukin-18 binding proteins, their preparation and use | |
| GB9927603D0 (en) | Use of a milk protein hydrolysate in the treatment of diabetes | |
| EP1110969A4 (en) | INTERLEUKIN 18 BINDING PROTEIN | |
| HUP9904237A3 (en) | Expression of globin proteins in plants | |
| EE200000147A (en) | April - a new growth protein | |
| AU2001255436A1 (en) | Protein expression system arrays and use in biological screening | |
| EP1268510A4 (en) | METHOD AND MATERIALS RELATING TO POLYPEPTIDES AND POLYNUCLEOTIDES LIKE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN | |
| EP1295939A4 (en) | INSULINOID GROWTH FACTOR BINDING PROTEIN | |
| EP1534744A4 (en) | BINDING PROTEINS MODIFIED TO ANALOGUE GROWTH FACTOR OF INSULIN | |
| DE69938579D1 (en) | Extracellular matrix proteins with modified amino acids | |
| EP0796321A4 (en) | PROTEINS BINDING TO PROTEIN E2 | |
| GB9713430D0 (en) | Materials and methods relating to a plant regulatory protein | |
| EP0738277A4 (en) | NOVEL PROTEINS BINDING TO RETINOBLASTOMA PROTEIN AND CODING DNA SEQUENCES THEREOF | |
| ZA974529B (en) | Human calcium sensor protein fragments thereof and dna encoding same | |
| AU2001262934A1 (en) | Human fgf-20 nucleic acids and polypeptides | |
| AU2002221428A1 (en) | Novel polypeptide human polyadenylation binding protein 20.13 and polynucleotideencoding it | |
| GB9724307D0 (en) | Improvements relating to protein accumulation | |
| HUP0200809A3 (en) | Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor | |
| IL140124A0 (en) | Soy hydrolysate and use in insect control | |
| EP1323734A4 (en) | BINDING PROTEIN TO IRAP | |
| EP1142999A4 (en) | Novel protein and dna thereof | |
| AU4895499A (en) | Polypeptide with immunogenic properties and with a protein with modified biological functions | |
| EP1111047A4 (en) | Novel protein and dna thereof | |
| IL139595A0 (en) | Human protein c polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20021015 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20030411 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NUVELO INC. |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NUVELO, INC. |
|
| 17Q | First examination report despatched |
Effective date: 20040205 |
|
| 17Q | First examination report despatched |
Effective date: 20040205 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20080218 |